HBPL Study of the Impact of the NK1 Antagonist Aprepitant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01176591
Recruitment Status : Terminated
First Posted : August 6, 2010
Last Update Posted : April 3, 2014
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Jennifer Plebani, University of Pennsylvania

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Primary Completion Date : September 2013
  Study Completion Date : December 2013

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 18, 2015 March 30, 2015
2 May 26, 2015 June 10, 2015
3 March 2, 2016 April 1, 2016
4 October 25, 2016 December 16, 2016
5 December 20, 2016 February 10, 2017
6 September 22, 2017 October 23, 2017